UMMS Affiliation

Department of Medicine, Division of Gastroenterology

Publication Date

10-10-2012

Document Type

Article

Subjects

Hepacivirus; Hepatitis C, Chronic; Interferon-alpha

Disciplines

Digestive System Diseases | Immunology and Infectious Disease | Virus Diseases

Abstract

BACKGROUND AND AIMS: Hepatitis C virus (HCV) is difficult to eradicate and type III interferons (IFN-lambda, composed of IL-28A, IL-28B and IL-29) are novel therapeutic candidates. We hypothesized that IFN-lambda have immunomodulatory effects in HCV- infected individuals.

MATERIALS AND METHODS: We analyzed the expression of IFN-lambda and its receptor (composed of IL-10R2 and IFN-lambdaR subunits) in the blood and livers of patients with chronic (c)HCV infection compared to controls (those who cleared HCV by sustained virological response, SVR, and those with liver inflammation of non-viral origin, non-alcoholic steatohepatitis, NASH). We also compared the proliferative capacity of dendritic cells (DCs) obtained from healthy individuals and those with chronic HCV using a mixed leukocyte reaction combined with 3H-Td incorporation. In addition, the composition of the IFN-lambda receptor (IFN-lambdaR) on myeloid DCs, plasmacytoid DCs, PBMCs, and T cells was determined by FACS analysis.

RESULTS: We report that the expression of IFN-lambda protein in serum and mRNA in liver is increased in cHCV patients, but not in those with HCV SVR or NASH, compared to controls. Liver level of IFN-lambdaR mirrored the expression of serum IFN-lambda and was higher in cHCV, compared to controls and HCV-SVR patients, suggesting that elevation of IFN-lambda and IFN-lambdaR are HCV-dependent. We further identified that innate immune cell populations expressed complete IFN-lambda receptor. In vitro, recombinant IFN-lambda promoted differentiation of monocyte-derived dendritic cells (DCs) into a phenotype with low T cell stimulatory capacity and high PD-L1 expression, which further promoted expansion of existing regulatory T cells. IFN-lambda-DCs failed to induce de novo generation of regulatory T cells. The inhibitory capacity of IFN-lambda-DCs was counteracted by recombinant IL-12 and by neutralization of the PD-1/PD-L1 system.

CONCLUSIONS: Our novel findings of the immunomodulatory effect of IFN-lambda contribute to the understanding of the anti-inflammatory and/or anti-viral potential of IFN-lambda in cHCV.

Comments

Citation: Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, et al. (2012) Type III Interferons, IL-28 and IL-29, Are Increased in Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+ Regulatory T Cells. PLoS ONE 7(10): e44915. doi:10.1371/journal.pone.0044915 Link to article on publisher's site

Copyright: © Dolganiuc et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Related Resources

Link to Article in PubMed

Journal/Book/Conference Title

PloS one

PubMed ID

23071503

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.